In Brief 90 cancer groups and centers urge CMS to rescind proposed lung cancer screening reimbursement cuts September 23, 2016Vol.42 No.35
Drugs & Targets Dignity Health, Catholic Health Initiatives Launch Precision Medicine Alliance September 23, 2016Vol.42 No.35
Drugs & Targets ORIEN and HudsonAlpha announce new research collaboration September 23, 2016Vol.42 No.35
Drugs & Targets St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute agree to exchange cancer mutation data September 23, 2016Vol.42 No.35
Drugs & Targets Golden Meditech and MD Anderson announce creation of Cellenkos Inc. September 23, 2016Vol.42 No.35
Drugs & Targets EMA recommends conditional marketing authorization for olaratumab September 23, 2016Vol.42 No.35
Drugs & Targets Novartis, MEI Pharma. Receive Breakthrough Therapy Designations September 22, 2016Vol.39 No.08
